About N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide
N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide (PubChem CID 138590644) has the molecular formula C17H19N5O2
and a molecular weight of 325.37 g/mol. Its IUPAC name is N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide.
Analyze N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide?
The IUPAC name of N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide (CID 138590644) is N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide.
What is the SMILES notation for N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide?
The canonical SMILES for N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide is CC(C)OCC(=O)Nc1cc2cc(-c3cncn3C)cnc2cn1.
What is the InChIKey of N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide?
The InChIKey is XMSGEFRUUIVVLJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H19N5O2/c1-11(2)24-9-17(23)21-16-5-12-4-13(6-19-14(12)7-20-16)15-8-18-10-22(15)3/h4-8,10-11H,9H2,1-3H3,(H,20,21,23).
What are the key properties of N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide?
N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide has a molecular weight of 325.37 g/mol, XLogP of 2.39, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(3-methylimidazol-4-yl)-1,7-naphthyridin-6-yl]-2-propan-2-yloxyacetamide is sourced from PubChem (CID 138590644), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).